Brief: Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager Therapy

Amgen

01/04/2026 13:34

Zai Lab Ltd 9688.HK:

ZAI LAB ANNOUNCES GLOBAL CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT TO EVALUATE NOVEL DLL3 ADC, ZOCILURTATUG PELITECAN, IN COMBINATION WITH A BISPECIFIC T-CELL ENGAGER THERAPY

ZAI LAB LTD - ANNOUNCES GLOBAL CLINICAL TRIAL COLLABORATION WITH AMGEN FOR ES-SCLC

Source text: ID:nBw28MYRka

Further company coverage: 9688.HK